Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
China Health GroupHKSE:00673 24 Market Cap is HK$554.86 Mil as of Aug. 12, 2026. GuruFocus rates HKSE:00673 with a GF Score™ of 24/100 and a GF Value™ of HK$0.24 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 122 Medical Distribution companies, China Health Group ranks worse than 61.48% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). China Health Group's share price for the quarter that ended in Mar. 2026 was HK$0.52. China Health Group's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 1,442.36 Mil. Therefore, China Health Group's market cap for the quarter that ended in Mar. 2026 was HK$750.03 Mil.
China Health Group's quarterly market cap
increased
from Mar. 2025 (HK$116.52 Mil) to Sep. 2025 (HK$291.61 Mil) and
increased
from Sep. 2025 (HK$291.61 Mil) to Mar. 2026 (HK$750.03 Mil).
China Health Group's annual market cap
declined
from Mar. 2024 (HK$455.04 Mil) to Mar. 2025 (HK$116.52 Mil) but then
increased
from Mar. 2025 (HK$116.52 Mil) to Mar. 2026 (HK$502.84 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. China Health Group's Enterprise Value for Today is HK$545.57 Mil.
China Health Group (HKSE:00673) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
China Health Group Market Cap Related Terms
China Health Group Market Cap Historical Data
* Premium members only.
The historical data trend for China Health Group's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:00673 vs MCK, COR, CAH: Market Cap Comparison
For the Medical Distribution subindustry, China Health Group's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Health Group Market Cap vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, China Health Group's Market Cap distribution charts can be found below:
* The bar in red indicates where China Health Group's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
China Health Group's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Health Group (HKSE:00673) has a Market Cap of HK$554.86 Mil as of Aug. 12, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on China Health Group and its competitors. According to the industry distribution chart, China Health Group ranks #75 out of 122 companies in the Medical Distribution industry, placing it in the top 61.5%.
Is China Health Group's Market Cap too high?
China Health Group's current Market Cap is HK$554.86 Mil. Based on the distribution chart, China Health Group ranks #75 out of 122 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, China Health Group has a GF Score™ of 24/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does China Health Group's Market Cap compare to MCK and COR?
According to the Medical Distribution industry distribution chart, China Health Group ranks #75 out of 122 companies for Market Cap. This places China Health Group in the lower half of its industry. The industry median Market Cap is 132.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Distribution company?
The median Market Cap among Medical Distribution companies is 132.20, based on 122 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on China Health Group and its competitors. For the Medical Distribution industry, the median Market Cap is 132.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Health Group's current Market Cap is HK$554.86 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Health Group stock overvalued right now?
Based on GuruFocus' analysis, China Health Group (HKSE:00673) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.24, compared to a current price of HK$0.40 — trading 66.7% above its estimated fair value. The current Market Cap is HK$554.86 Mil. China Health Group's overall GF Score™ is 24/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For China Health Group (HKSE:00673), the current Market Cap is HK$554.86 Mil as of Aug. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Health Group (HKSE:00673) Overvalued in 2026?
Based on GuruFocus' analysis, China Health Group stock appears to be overvalued.
The current stock price of HK$0.40 is trading 66.7% above its estimated GF Value™ of HK$0.24.
GuruFocus considers China Health Group to be Significantly Overvalued.
Key valuation signals for HKSE:00673:
Market Cap: HK$554.86 Mil
GF Value™: HK$0.24 vs. price of HK$0.40 (66.7% above fair value)
No single metric tells the full story. See the HKSE:00673 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Health Group Ltd is an investment holding company. It is principally engaged in the distribution and service of medical equipment and consumables, provision of hospital operation and management services, and business factoring. It operates in the business in four segments: medical equipment and consumables distribution and service business; hospital operation and management services business; business service; and research and development and sale of functional food. It derives a majority of revenue from the Distribution and service in the medical equipment and consumables segment. Geographically, the group derives its revenue from the PRC.
24GF Score
Get the complete analysis for HKSE:00673
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00673 has been successfully added to your 
